NasdaqGS:CLBTSoftware
Is Cellebrite DI (CLBT) Cheap As Lower 2026 Guidance And A CEO Change Hit?
Cellebrite DI guidance cut and CEO transition put the stock in focus
Cellebrite DI (NasdaqGS:CLBT) has drawn fresh attention after lowering its full year 2026 revenue outlook and confirming an internal CEO transition that installs Shiven Ramji as chief executive and board member.
See our latest analysis for Cellebrite DI.
At a share price of US$11.14, Cellebrite DI has seen short term momentum weaken, with the 7 day share price return down 29.94% and the year to date share price return down...